Imperative Care, a company with two FDA-cleared devices for stroke treatment, recently raised $160 million in a funding round led by D1 Capital Partners. It’s using the funds to build a portfolio of companies to treat stroke and vascular disease. 

PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://medcitynews.com/2021/07/after-raising-260m-imperative-care-looks-to-build-portfolio-of-stroke-care-companies/